We invest in companies that are focused on commercialization and have a clear business model
We strive to forge strategic distribution partnerships, refine marketing messaging, and sharpen clinical design to enable founders expedite market access.
Cloud-based infrastructure to help develop drug Candidates, novel biomarkers & clinical algorithms
World's most advanced fast and stentless Glaucoma treatment that lowers the intraocular pressure without the need for major invasive surgery
Pioneering medical technology focused on dialysis using regeneration technology for end-stage renal disease
Best-in-class treatment for patients with idiopathic pulmonary fibrosis, that has the potential to revolutionize the current standard of care